Skip to main content

Table 3 Acute side effects during treatment with HT and concurrent chemotherapy

From: Helical TomoTherapy for locally advanced or recurrent breast cancer

Common Toxicity Criteria (CTC)

All patients

Recurrence Treatment Group

Primary Treatment Group

Radiotherapy

n = 26

n = 12

n = 14

 Radiodermatitis °1

14 (53%)

6 (50%)

8 (57%)

 Radiodermatitis °2

6 (23%)

4 (33%)

2 (14%)

 Radiodermatitis °3

6 (23%)

2 (16.7%)

4 (28%)

 Dysphagia °1

10 (%)

5 (42%)

5 (36%)

 Lymphedema °3

3 (11%)

4 (33%)

1 (7%)

 Fatigue

12 (46%)

5 (42%)

7 (50%)

Chemotherapy

n = 11

n = 9

n = 2

 Leucopenia °1

6 (55%)

5 (55%)

1 (50%)

 Leucopenia 2

5 (42%)

4 (44%)

1 (50%)

 Anemia 1

6 (55%)

6 (67%)

 Anemia 2

3 (27%)

2 (22%)

1 (50%)

 Anemia 3

1 (9%)

1 (50%)

 Hand-foot-syndrome

2 (18%)

2 (22%)